Your session is about to expire
← Back to Search
Pre-surgical Aerobic Exercise for Cancer
Study Summary
This trial is designed to find the safest level of aerobic exercise for people with cancer and to see if there are any benefits to aerobic exercise for these patients. The study will use different doses of aerobic exercise to compare the effects and feasibility of the exercise. The study will also use apps and electronic devices to monitor the participants' lifestyle.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have surgery scheduled for my solid tumor at least 2 weeks after joining the study.I am a man taking hormone therapy for cancer.I have prostate cancer that has not been treated yet, but I am scheduled for surgery.I am not part of any other clinical trials that could affect this study's results, except those approved by the study leader.My cancer has spread to other parts of my body.I am older than 18 years.I have been diagnosed with endometrial, breast, or prostate cancer.I am older than 18 years.I'm sorry, but you haven't provided any specific criteria to rewrite. Could you please provide the specific criteria you would like me to summarize?I have received initial treatment for my cancer before any other main treatment.I had a lung biopsy within the last 14 days.I am not currently receiving treatment for any invasive cancer.I have a solid tumor and my surgery is scheduled at least 2 weeks after joining the study.I am considering a trial that is testing the safety of new doses.My trial is in the very early stages, testing if the treatment could work.I have early-stage breast cancer and finished a study with IRB# 15-147.I haven't used any hormone therapies like tamoxifen or anastrozole in the last 6 months.I have enough lung tissue samples from my biopsy for advanced testing.I have received cancer treatment that affects my whole body.
- Group 1: Pilot "Proof-of-Concept"
- Group 2: Phase 1a: Dose-Finding / Escalation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being recruited for this experiment?
"Confirmed. Clinicaltrials.gov has the latest information on this clinical trial, which was first posted in January 2021 and most recently updated April 2022. 84 participants are required from 8 different sites for its successful completion."
Are there still opportunities for participants to enroll in this clinical trial?
"According to the clinicaltrials.gov portal, this medical research is actively recruiting participants, with postings dated January 21st 2019 and revisions made on April 15th 2022."
How many facilities is this experiment being supervised in?
"This clinical trial is currently being administered at 8 different facilities, such as Memorial Sloan Kettering Nassau (Limited Protocol Activities) in Uniondale, Memorial Sloan Kettering Bergen (Limited Protocol Activities) in Montvale, and Memorial Sloan Kettering Commack (Limited Protocol Activities) in Commack. Additionally there are 5 other medical sites hosting the study."
Share this study with friends
Copy Link
Messenger